A Pilot Phase II Trial of Temozolomide in Leptomeningeal Metastases.
Phase of Trial: Phase II
Latest Information Update: 13 May 2013
At a glance
- Drugs Temozolomide (Primary)
- Indications Cancer metastases; Lymphoma; Solid tumours
- Focus Therapeutic Use
- 13 May 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 30 Mar 2010 New trial record